In clinical trials, the term reactogenicity refers to the property of a vaccine of being able to produce common, `expected” adverse reactions, especially excessive immunological responses and associated signs and symptoms—fever, sore arm at injection site, etc. (Much less frequently, the term has also been applied to therapeutic drug trials......
Type: Term Pronunciation: rē-ak-tō-je-nĭ-sĭ′tē Definitions: 1. State of being able to produce adverse reactions.
the capacity of a vaccine to produce adverse reactions.
The ability of a vaccine to cause adverse reactions, or the severity of adverse reactions it causes
Being able to produce adverse reactions.
Ability to cause an immunological reaction.
the capacity of a vaccine to produce adverse reactions.